11 Einträge gefunden

1. Detection of ESR1 Mutations in Single Circulating Tumor Cells on Estrogen Deprivation Therapy but Not in Primary Tumors from Metastatic Luminal Breast Cancer Patients

   1. Franken, André
   2. Honisch, Ellen
   3. Reinhardt, Florian
   4. Meier-Stiegen, Franziska
   5. Yang, Liwen
   6. Jaschinski, Sandra
   7. Esposito, Irene

   2020 - Forschungsinformationssystem des UKE
2. A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

   1. Karn, Thomas
   2. Meissner, Tobias
   3. Weber, Karsten E
   4. Solbach, Christine
   5. Denkert, Carsten
   6. Engels, Knut
   7. Fasching, Peter A

   2020 - Forschungsinformationssystem des UKE
3. Update Breast Cancer 2020 Part 1 - Early Breast Cancer:Consolidation of Knowledge About Known Therapies

   1. Schneeweiss, Andreas
   2. Hartkopf, Andreas D
   3. Müller, Volkmar
   4. Wöckel, Achim
   5. Lux, Michael P
   6. Janni, Wolfgang
   7. Ettl, Johannes

   2020 - Forschungsinformationssystem des UKE
4. ABC5 International Consensus Conference on Advanced Breast Cancer, Lisbon, 16 November 2019:Commentary by the German panel of experts on the ABC5 voting results

   1. Untch, Michael
   2. Würstlein, Rachel
   3. Lüftner, Diana
   4. Haidinger, Renate
   5. Fasching, Peter A
   6. Augustin, Doris
   7. Briest, Susanne

   2020 - Forschungsinformationssystem des UKE
5. Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab

   1. Michel, Laura L
   2. Hartkopf, Andreas D
   3. Fasching, Peter A
   4. Kolberg, Hans-Christian
   5. Hadji, Peyman
   6. Tesch, Hans
   7. Häberle, Lothar

   2020 - Forschungsinformationssystem des UKE
6. Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

   1. Schneeweiss, Andreas
   2. Ettl, Johannes
   3. Lüftner, Diana
   4. Beckmann, Matthias W
   5. Belleville, Erik
   6. Fasching, Peter A
   7. Fehm, Tanja N

   2020 - Forschungsinformationssystem des UKE
7. Update Breast Cancer 2020 Part 4 - Advanced Breast Cancer

   1. Tesch, Hans
   2. Müller, Volkmar
   3. Wöckel, Achim
   4. Ettl, Johannes
   5. Belleville, Erik
   6. Schütz, Florian
   7. Hartkopf, Andreas

   2020 - Forschungsinformationssystem des UKE
8. Update Breast Cancer 2020 Part 3 - Early Breast Cancer

   1. Huober, Jens
   2. Schneeweiss, Andreas
   3. Hartkopf, Andreas D
   4. Müller, Volkmar
   5. Lux, Michael P
   6. Janni, Wolfgang
   7. Ettl, Johannes

   2020 - Forschungsinformationssystem des UKE
9. Association of Germline Variant Status With Therapy Response in High-risk Early-Stage Breast Cancer: A Secondary Analysis of the GeparOcto Randomized Clinical Trial

   1. Pohl-Rescigno, Esther
   2. Hauke, Jan
   3. Loibl, Sibylle
   4. Möbus, Volker
   5. Denkert, Carsten
   6. Fasching, Peter A
   7. Kayali, Mohamad

   2020 - Forschungsinformationssystem des UKE
10. International Consensus Conference for Advanced Breast Cancer, Lisbon 2019:ABC5 Consensus - Assessment by a German Group of Experts

    1. Thomssen, Christoph
    2. Lüftner, Diana
    3. Untch, Michael
    4. Haidinger, Renate
    5. Würstlein, Rachel
    6. Harbeck, Nadia
    7. Augustin, Doris

    2020 - Forschungsinformationssystem des UKE
11. Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial

    1. de Gregorio, Amelie
    2. Häberle, Lothar
    3. Fasching, Peter A
    4. Müller, Volkmar
    5. Schrader, Iris
    6. Lorenz, Ralf
    7. Forstbauer, Helmut

    2020 - Forschungsinformationssystem des UKE